April 2016 FDA Recall Norditropin by Novo Nordisk Inc
D-0956-2016 - Defective Delivery System; may have a low frequency assembly fault which may result in pens block during the so-called "air shot" step

This Class II drug recall was voluntarily initiated by Novo Nordisk Inc on April 27, 2016 for the product Norditropin. The FDA reported the reason for recall as defective delivery system; may have a low frequency assembly fault which may result in pens block during the so-called "air shot" step. The product was distributed Nationwide and the recall is currently terminated.

Recall Number: D-0956-2016

Reason for Recall
Defective Delivery System; may have a low frequency assembly fault which may result in pens block during the so-called "air shot" step
Initiated
04-27-2016
Reported
06-15-2016
Quantity
723 pens

Recall Profile & Regulatory Data

Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Norditropin FlexPro Somatropin (rDNA origin) injection, 30 mg/3 mL Prefilled Pen, Rx only, Novo Nordisk Inc., Plainsboro, NJ --- NDC 0169-7703-21

Batch or Lot Expiration Information

Lot# Lot Number FC70222